Mohammed Alghamdi

King Saud bin Abdulaziz University for Health Sciences

Papers

Total Citations

H-Index

About

Mohammed Alghamdi is a urologic oncology researcher focused on advancing surgical management of kidney cancer, particularly through nephron-sparing approaches. His work centers on optimizing partial nephrectomy outcomes, comparing surgical modalities, and balancing oncological control with renal function preservation. His most cited paper, "Partial Nephrectomy: A Comparison between Different Modalities" (2021, 7 citations), addresses the rising incidence of kidney cancer—including a 33% increase in Saudi Arabia—and establishes partial nephrectomy as the gold standard for T1 renal masses. In a subsequent influential study (2023, 3 citations), Alghamdi tackles the controversial application of partial nephrectomy in locally advanced T3a renal cell carcinoma, demonstrating that nephron-sparing surgery can preserve renal function without compromising oncological outcomes. This work challenges conventional treatment paradigms and expands surgical candidacy for patients with more advanced disease. Alghamdi’s research is particularly valuable for its focus on real-world outcomes in the Saudi population, addressing regional epidemiological trends while contributing to global urologic oncology literature. His comparative analyses provide evidence-based guidance for surgeons navigating the trade-offs between radical and partial nephrectomy across different disease stages.